Table 2 Mucosal anti-gp140 response rates are significantly increased vs. anti-gp120 and gp41 responses in all mucosal compartments.
From: Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
Rate (%) | P-value | PFWERa | |
|---|---|---|---|
gp120 vs. gp140 | |||
Cervical sponge | 48 vs. 71 | 0.0001 | 0.0010*** |
Rectal sponge | 33 vs. 52 | 0.0002 | 0.0015** |
Saliva | 24 vs. 39 | <0.0001 | 0.0005*** |
Seminal plasma | 44 vs. 76 | <0.0001 | <0.0001*** |
gp120 vs. gp41 | |||
Cervical sponge | 48 vs. 51 | 0.8145 | >0.9999 |
Rectal sponge | 33 vs. 33 | >0.999 | >0.9999 |
Saliva | 24 vs. 27 | 0.4328 | >0.9999 |
Seminal plasma | 44 vs. 44 | >0.9999 | >0.9999 |
gp140 vs. gp41 | |||
Cervical sponge | 71 vs. 51 | 0.0005 | 0.0024** |
Rectal sponge | 52 vs. 33 | 0.0002 | 0.0015** |
Saliva | 39 vs. 27 | 0.0017 | 0.0070** |
Seminal plasma | 76 vs. 44 | <0.0001 | <0.0001*** |